-transparent.png){kind=logo}
OBJECTIVE To obtain a synthetic anti-complement inhibitor which has stronger activity than FUT-175 (nafamostat mesilate), as a synthetic ester derivative containing amidino and guanidino groups. METHODS We synthesized several modified compounds of FUT-175. The anti-complement activities were measured using synthetic substrates and complement-mediated hemolysis in vitro. The anti-complement activity in vivo was evaluated via Forssman systemic shock in guinea pigs. RESULTS FUT-175 inhibited C1r and C1s with IC50s of 1.7x10(-6) and 3.2x10(-7) M, respectively. Inhibitory activities were decreased by substitution of the amidino group with a hydrogen atom (compound 2), but not the guanidino group with a hydrogen atom (compound 3). Compound 6, in which the benzene ring of compound 3 was substituted with a furan ring, inhibited C1r and the complement-mediated hemolysis in high-diluted serum with higher potency than FUT-175. The inhibitory activity of compound 6 in hemolysis was weakened in low diluted serum. Compound 7 had a guanidino group inserted into compound 6; however, Compound 7 strongly inhibited hemolysis even in low-diluted serum, and suppressed Forssman systemic shock more potently than both FUT-175 and compound 6. CONCLUSIONS These data suggest that the 2-furylcarboxylic acid derivatives have a strong potential for inhibiting the activities of the complement, and the guanidino group was required to retain high inhibitory activities in vivo, and compound 7 is a hopeful anti-complement agent.
N Ueda, and
A Midorikawa, and
Y Ino, and
M Oda, and
K Nakamura, and
S Suzuki, and
M Kurumi
February 1970,
FEBS letters,
N Ueda, and
A Midorikawa, and
Y Ino, and
M Oda, and
K Nakamura, and
S Suzuki, and
M Kurumi
April 2005,
Bioorganic & medicinal chemistry,
N Ueda, and
A Midorikawa, and
Y Ino, and
M Oda, and
K Nakamura, and
S Suzuki, and
M Kurumi
November 2009,
Bioorganic & medicinal chemistry letters,
N Ueda, and
A Midorikawa, and
Y Ino, and
M Oda, and
K Nakamura, and
S Suzuki, and
M Kurumi
February 2020,
Fish & shellfish immunology,
N Ueda, and
A Midorikawa, and
Y Ino, and
M Oda, and
K Nakamura, and
S Suzuki, and
M Kurumi
July 1995,
Journal of medicinal chemistry,
N Ueda, and
A Midorikawa, and
Y Ino, and
M Oda, and
K Nakamura, and
S Suzuki, and
M Kurumi
November 1968,
Hoppe-Seyler's Zeitschrift fur physiologische Chemie,
N Ueda, and
A Midorikawa, and
Y Ino, and
M Oda, and
K Nakamura, and
S Suzuki, and
M Kurumi
January 2006,
Acta poloniae pharmaceutica,
N Ueda, and
A Midorikawa, and
Y Ino, and
M Oda, and
K Nakamura, and
S Suzuki, and
M Kurumi
March 2001,
The Journal of comparative neurology,
N Ueda, and
A Midorikawa, and
Y Ino, and
M Oda, and
K Nakamura, and
S Suzuki, and
M Kurumi
January 1971,
Archives of biochemistry and biophysics,
N Ueda, and
A Midorikawa, and
Y Ino, and
M Oda, and
K Nakamura, and
S Suzuki, and
M Kurumi
November 2001,
Chemistry & biology,
